As of Dec 18, 2024, Esperite's P/E ratio was -1.02, a -49.25% change from the -2.01 P/E ratio recorded in the previous year.

The Esperite P/E history

Esperite Aktienanalyse

What does Esperite do?

Esperite NV is a company based in the Netherlands that specializes in the development, production, and marketing of stem cell and cell therapies. It focuses on creating groundbreaking therapies for the treatment of serious diseases and aims to market them worldwide. Its business model includes three main segments: Life Science, Consumer Healthcare, and Branding. The Life Science segment focuses on developing stem cell and cell therapies for the treatment of diseases such as autism, cancer, and degenerative disorders. The Consumer Healthcare segment offers products related to pregnancy and fertility assistance. The Branding segment involves the development and marketing of high-quality cosmetic products. Esperite's flagship product is CryoSave, a solution for the long-term preservation of stem cells from umbilical cord blood. Esperite ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Esperite's P/E Ratio

The Price to Earnings (P/E) Ratio of Esperite is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Esperite's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Esperite is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Esperite’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Esperite stock

What is the price-to-earnings ratio of Esperite?

The price-earnings ratio of Esperite is currently -1.02.

How has the price-earnings ratio of Esperite changed compared to last year?

The price-to-earnings ratio of Esperite has increased by -49.25% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Esperite high compared to other companies?

Yes, the price-to-earnings ratio of Esperite is high compared to other companies.

How does an increase in the price-earnings ratio of Esperite affect the company?

An increase in the price-earnings ratio of Esperite would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Esperite affect the company?

A decrease in the price-earnings ratio of Esperite would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Esperite?

Some factors that influence the price-earnings ratio of Esperite are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Esperite pay?

Over the past 12 months, Esperite paid a dividend of 0.08 EUR . This corresponds to a dividend yield of about 869.57 %. For the coming 12 months, Esperite is expected to pay a dividend of 0 EUR.

What is the dividend yield of Esperite?

The current dividend yield of Esperite is 869.57 %.

When does Esperite pay dividends?

Esperite pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Esperite?

Esperite paid dividends every year for the past 0 years.

What is the dividend of Esperite?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Esperite located?

Esperite is assigned to the 'Health' sector.

Wann musste ich die Aktien von Esperite kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Esperite from 6/14/2012 amounting to 0.08 EUR, you needed to have the stock in your portfolio before the ex-date on 5/18/2012.

When did Esperite pay the last dividend?

The last dividend was paid out on 6/14/2012.

What was the dividend of Esperite in the year 2023?

In the year 2023, Esperite distributed 0 EUR as dividends.

In which currency does Esperite pay out the dividend?

The dividends of Esperite are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Esperite

Our stock analysis for Esperite Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Esperite Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.